PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.\', \'Division of Rheumatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.\', \'Division of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.\', \'Division of Infectious Disease, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.\', \'Michigan Clinical Research Unit, University of Michigan, Ann Arbor, Michigan, USA.\', \'Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.\', \'Division of Rheumatology, University of Washington, Department of Medicine, Seattle, Washington, USA.\', \'Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.\', \'Laboratory of Vascular Thrombosis and Inflammation, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/JLB.3COVCRA0720-359R
?:hasPublicationType
?:journal
  • Journal of leukocyte biology
is ?:pmid of
?:pmid
?:pmid
  • 32869342
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.04
?:rankingScore_hIndex
  • 171
is ?:relation_isRelatedTo_publication of
?:title
  • Neutrophil calprotectin identifies severe pulmonary disease in COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all